Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Other Working Capital Changes (2022 - 2025)

Oramed Pharmaceuticals' Other Working Capital Changes history spans 4 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes changed N/A year-over-year to $1.1 million; the TTM value through Dec 2025 reached $974000.0, changed N/A, while the annual FY2025 figure was $998000.0, 2220.93% up from the prior year.
  • Other Working Capital Changes reached $1.1 million in Q4 2025 per ORMP's latest filing, up from -$60000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.4 million in Q3 2022 to a low of -$1.3 million in Q2 2023.
  • Average Other Working Capital Changes over 4 years is -$47461.5, with a median of -$59000.0 recorded in 2024.
  • The largest YoY upside for Other Working Capital Changes was 102.42% in 2024 against a maximum downside of 125.0% in 2024.
  • A 4-year view of Other Working Capital Changes shows it stood at -$735000.0 in 2022, then fell by 11.16% to -$817000.0 in 2023, then soared by 92.78% to -$59000.0 in 2024, then surged by 1898.31% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Other Working Capital Changes are $1.1 million (Q4 2025), -$60000.0 (Q1 2025), and -$59000.0 (Q3 2024).